Addus HomeCare's (ADUS) Hold (C+) Rating Reaffirmed at Weiss Ratings

Key Points

• Addus HomeCare's stock has been reaffirmed with a "hold (C+)" rating by Weiss Ratings, while various analysts have provided target price adjustments ranging from $109 to $150.
• The company reported a 21.8% year-over-year revenue growth for its most recent quarter, with earnings per share (EPS) of $1.49, slightly above the consensus estimate of $1.45.
• Insider transactions included significant sales, with both the CEO and EVP decreasing their share ownership by over 11% and 13% respectively in August, raising concerns about insider confidence.

Addus HomeCare (NASDAQ:ADUS - Get Free Report)'s stock had its "hold (c+)" rating reaffirmed by analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

A number of other analysts also recently weighed in on ADUS. Royal Bank Of Canada boosted their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the stock an "outperform" rating in a report on Friday, August 22nd. Macquarie restated an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. Barclays boosted their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the stock an "underweight" rating in a report on Tuesday, August 19th. TD Cowen boosted their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Finally, JMP Securities restated a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Wednesday, July 16th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $138.89.

Addus HomeCare Price Performance

NASDAQ ADUS traded up $3.10 on Wednesday, reaching $113.74. The company had a trading volume of 64,803 shares, compared to its average volume of 183,197. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $2.10 billion, a PE ratio of 25.00, a price-to-earnings-growth ratio of 1.72 and a beta of 0.86. The firm's 50 day moving average price is $113.25 and its 200 day moving average price is $109.58. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The company had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. Addus HomeCare's revenue for the quarter was up 21.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.35 EPS. As a group, equities analysts predict that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Buying and Selling at Addus HomeCare

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the sale, the executive vice president directly owned 56,980 shares of the company's stock, valued at $6,656,403.60. The trade was a 11.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the sale, the chief executive officer directly owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,310 shares of company stock valued at $3,958,375 in the last three months. Company insiders own 4.50% of the company's stock.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently modified their holdings of the business. Premier Fund Managers Ltd purchased a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $726,000. Harbor Capital Advisors Inc. lifted its position in shares of Addus HomeCare by 4.5% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 67,219 shares of the company's stock worth $7,743,000 after purchasing an additional 2,906 shares during the period. Strs Ohio purchased a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $653,000. Punch & Associates Investment Management Inc. lifted its position in shares of Addus HomeCare by 2.1% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 110,286 shares of the company's stock worth $10,906,000 after purchasing an additional 2,260 shares during the period. Finally, HighTower Advisors LLC lifted its position in shares of Addus HomeCare by 62.4% in the 1st quarter. HighTower Advisors LLC now owns 4,671 shares of the company's stock worth $462,000 after purchasing an additional 1,795 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.